MedPath
NMPA Approval

Bevacizumab Injection

国药准字S20250004

January 8, 2025

Drug Information

贝伐珠单抗注射液

生唯宁

注射剂

100mg:4ml

生物制品

January 8, 2025

Company Information

Applicant Company

上海市长宁区延安西路1262号

Manufacturing Company

上海市长宁区安顺路350号-1

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

贝伐珠单抗注射液 - NMPA 批准文号 | MedPath